4
Npt2b gene. 1 2 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 Biochemical Journal. This is an Accepted Manuscript. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date-version is available at https://doi.org/10.1042/BCJ20190716
Introduction 1
Inorganic phosphate (Pi) homeostasis in mammals is strictly controlled through the balance 2 of intestinal absorption and renal excretion/reabsorption [1, 2] . The uptake of Pi is mediated by 3 type II sodium-dependent phosphate co-transporters (Npt2) in the brush-border membrane of 4 the small intestine and renal proximal tubule [1, 2] . Npt2a and Npt2c are responsible for most Pi 5 reabsorption in the kidney and can be regulated by dietary Pi, 1,25-dihydroxyvitamin D 3 6
[1,25(OH) 2 D 3 ], all-trans retinoic acid (ATRA), and hormonal factors such as parathyroid 7 hormone (PTH), fibroblast growth factor 23 (FGF23), and tumor necrosis factor- (TNF) 8
[1−6]. Npt2b plays a critical role in intestinal Pi absorption and its expression is regulated by 9 dietary Pi, 1,25(OH) 2 D 3 , FGF23, epidermal growth factor (EGF), TNF and nuclear factor 1 10 (NF1) [1, 7−14] . 11
Disturbance of Pi homeostasis can cause important clinical disorders. Hyperphosphatemia, 12 which is associated with the pathophysiology of chronic kidney disease (CKD), can lead to 13 vascular calcification, which has been linked to increased cardiovascular morbidity and mortality 14 [15] . The regulation of the intestinal Pi absorption mediated by Npt2b is a possible therapeutic target 15 to control hyperphosphatemia in CKD [16] . In fact, Schiavi et al. suggested that targeting Npt2b in 16 addition to using dietary Pi binders may be a therapeutic approach to modulate serum Pi in CKD 17 [17] . Aside from this, the expression of Npt2b has also been detected in various tissues, 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 7 including the small intestine, lung, kidney, testis, and liver [18] . Npt2b is also involved in the 1 reuptake of phosphate for the synthesis of surfactant proteins in the lung [19, 20] . Mutations in 2 the Npt2b gene are linked to pulmonary alveolar microlithiasis (PAM), an autosomal recessive 3 disorder characterized by the deposition of calcium phosphate microlith, and testicular 4 microlithiasis (TM)a disease that is associated with cancer and infertility [21] . 5
Transcription factors precisely control the diversity and specificity of the complex patterns 6 of gene regulation. The transcription factor CCAAT/enhancer-binding proteins (C/EBPs), of 7 which there are six members (C/EBP, C/EBP, C/EBP, C/EBP, C/EBP, and C/EBP), are 8 involved in adipocyte differentiation, energy metabolism, immunity, and inflammation [22, 23] . 9
In addition, C/EBP homologue protein (CHOP), which is activated by endoplasmic reticulum 10 (ER) stress, mediates TNF-and CKD-induced vascular calcification [24−26] . We recently 11 reported that C/EBP contributes to vascular calcification via the upregulation of the expression 12 of type III sodium-dependent phosphate co-transporters (PiT1 and PiT2) [27] . The 13 double-knockout Cebpa/Cebpb mice generate an early embryonic lethal phenotype [ University Graduate School. The animals were housed in pathogen-free conditions and 5 maintained under a standard 12 hr light-dark cycle with free access to water. Briefly, pregnant 6
Wistar rats (Japan SLC, Shizuoka, Japan) were fed an altered vitamin A-deficient AIN93-G diet 7 (Oriental Yeast, Osaka, Japan) containing 0.6% Pi and 0.6% Ca (VAD) or an altered AIN93-G 8 diet (Oriental Yeast) containing 0.6% Pi and 0.6% Ca (control) from the 14th day of gestation 9 until the pups were weaned. Pups (male) were continued on each diet as discussed above until 10 they were killed at 7 weeks of age. The VAD group was randomly divided into two groups and 11 intraperitoneally administrated a total of 1 mg/kg body weight of ATRA or DMSO prepared in 12 500 l sterile saline. The control group was intraperitoneally administrated the same dose of 13 DMSO. Each group (n = 4 per group) of rats was fasted for 18 hr in metabolic cages with water 14 ad libitum before sacrifice with a total of 0.1 mg/kg body weight of buprenorphine 15 hydrochloride and a total of 50 mg/kg body weight of pentobarbital sodium salt, and the 16 removal of tissues. Composition of the diets was described previously [4] . The present study 17 was approved by the Animal Experimentation Committee of Tokushima University School of 18 
Preparation of brush border membrane vesicles (BBMVs) and Pi uptake 2
BBMVs were prepared from rat small intestine and kidney by the Ca 2+ precipitation method as 3 described previously [3] . The uptake of 32 P into BBMVs was measured by a rapid filtration 4 technique. Ten l of vesicle suspension was added to 90 l of incubation solution that was 5 composed of 100 mM NaCl or choline chloride, 100 mM mannitol, 20 mM HEPES/Tris, and 6 0.1 mM KH 2 32 PO 4 , and the preparation was incubated at 20˚C. Na + -dependent and 7 Na + -independent Pi uptake were measured as described previously [35] . 8 9
Western blot analysis 10
Protein samples were heated at 95˚C for 5 min in sample buffer in the presence of 5% 11 2-mercaptoethanol and subjected to SDS-PAGE. The separated proteins were transferred by 12 electrophoresis to polyvinylidene difluoride transfer membranes (Immobilon-P, Millipore, MA, 13 USA). The membranes were treated with diluted affinity-purified anti-Npt2a (1:5,000), and 14 anti-Npt2c (1:500), and anti-Npt2b (1:2,000) antibody [8] . Mouse anti--actin monoclonal 15 antibody was used as an internal control. Goat anti-rabbit IgG(H+L)-HRP conjugate (1:2,000) 16 was utilized as the secondary antibody, and signals were detected using the ECL Plus system. 17
Quantitative PCR analysis 1
Extraction of total RNA, cDNA synthesis, and real-time PCR were performed as described 2
previously [4] . The primer sequences (Npt2b, C/EBP, and C/EBP) for PCR amplification are 3 shown in Supplementary Table S1 . Other primer sequences (Npt2a, Npt2c, PiT1, PiT2, and 4 -actin) were described previously [4] . Amplification products were then analyzed by a melting 5 curve, which confirmed the presence of a single PCR product in all reactions (apart from 6 negative controls). The PCR products were quantified by fit-point analysis, and results were 7 normalized to that of -actin. 
Reporter plasmid construction 10
Luciferase reporter plasmids prNp2b-1.8k, prNp2b-800, prNp2b-67, prNp2b-55, pmNp2b-1.7k, 11 pmNp2b-700, pmNp2b-39, and phNp2b-1.5k were constructed by PCR amplification of rat, 12 mouse, or human genomic DNA as a template using gene-specific primers (Supplementary 13 Table S2 ). These PCR products were subcloned into a pGL-3 or pGL-4.19 vector (Promega, 14 Madison, WI, USA). Reporter plasmid prNp2b-180 was cloned by the digestion of prNp2b-800 15
using XhoI restriction enzyme. Reporter plasmids phNp2b-1.1k, phNp2b-200, and phNp2b+17 16 were cloned by the digestion of phNp2b-1.5k using SacI/HindIII, SacI/ApaI, and SmaI 17 restriction enzymes, respectively. Mutated reporter plasmids prNp2b-180-Mut-GC-box 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020
pmNp2b-700-Mut-GC-box (mMut-G), and pmNp2b-700-Mut-C/EBP (mMut-C) were 2 constructed with the QuikChange ® site-directed mutagenesis kit using the oligonucleotides 3 shown in Supplementary Table S2 . The -galactosidase expression vector pCMV- 4 (CLONTECH, Palo Alto, CA, USA) was used as an internal control. Each plasmid was purified 5
with PureYield TM Plasmid Midiprep System (Promega). 6 7 Transfection and luciferase assay 8 NIH3T3 cells were obtained from Riken Cell Bank, Tokyo, Japan. NIH3T3 cells were cultured 9 in DMEM at 37˚C in an atmosphere containing 5% CO 2 . The growth medium was 10 supplemented with 10% (v/v) FBS, 100 units/ml penicillin, 100 g/ml streptomycin and 1 mM 11 sodium pyruvate. Mouse RAR, RAR and RAR expression vectors (pSG5-RAR, 12 pSG5-RAR and pSG5-RAR and mouse RXR expression vector (pSG5-RXR were 13 kindly provided by Dr. P. Chambon. Mouse C/EBPand C/EBP expression vectors 14 (pcDNA3.1-C/EBP and pcDNA3.1-C/EBP were constructed as previously described [36] . 15 Transfection was performed as described previously [4] . Cells were then treated with several 16 concentrations of ATRA, TTNPB or ethanol as vehicle control for an additional 16 hr. 17
Luciferase assay was performed as described previously [4] . 18 Generated proteins were used for EMSAs. 12 13 EMSA 14 EMSA was performed as described previously [3] . Double-stranded nucleotides for 15
Npt2b-C/EBP and Npt2b-C/EBP-Mutant (Mut) were synthesized ( Supplementary Table S3 ). 16
Purified DNA fragments were radiolabeled with [-32 P] ATP (110 TBq/mmol) using T 4 17 polynucleotide kinase. Nuclear extracts (RARpSG5-RXRand C/EBPwere prepared as 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 described previously [4] . Briefly, the NIH-3T3 cells were cultured in 35-mm dishes to 90% 1 confluence and transfected with pSG5-RAR pSG5-RXRand pcDNA3.1-C/EBPPrepared 2 nuclear extracts (15 g) were incubated with the radiolabeled probe in binding buffer [10 mM 3 (Tris-HCl), pH7.5, 1 mM DTT, 1 mM EDTA, 10% Glycerol, 1 mM MgCl 2 , 0.25 mg/ml bovine 4 serum albumin, 2.5 g/ml salmon sperm DNA and 2 g poly(dI-dC)] in a final volume of 20 l 5 for 30 min at room temperature. Specificity of the binding reaction was determined with a 6 100-fold molar excess of the indicated cold competitor oligonucleotide. The reaction mixture 7
was then subjected to electrophoresis on a 5% polyacrylamide gel with 0.25 × TBE running 8 buffer for two hr at 150 V. The gel was dried and analyzed with a Fujix Bio-imaging analyzer 9
(BAS-1500, Fuji-film, Tokyo, Japan). 10 11
Statistical analysis 12
Data were collected from more than 2 independent experiments and were reported as the means 13 ± S.E.M. Statistical analysis for 2-group comparison was performed using a 2-tailed Student's t-14 test, or one-way ANOVA with a Student-Newman post-hoc test for multi-group 15 comparison. All data analysis was performed using GraphPad Prism 5 software 16 (Graphpad Software, San Diego, CA, USA). p < 0.05 was considered statistically Previously, we reported that VAD rats had decreased Pi uptake, however, the effect of ATRA on 4 the intestinal Pi uptake remains unclear [4] . Furthermore, we did not examine the effects of 5 ATRA treatment on phosphate homeostasis in VAD rats. We made VAD rats and these rats were 6 treated with a total of 1 mg/kg body weight of ATRA. Because ATRA cannot be converted to 7 retinol, plasma levels of retinol were undetectable in both VAD and VAD+ATRA rats, which 8 was in line with our expectations (control: 511 ± 12.2 g/dl). Although the plasma Pi and Ca 9 levels were not changed among three groups of rats, ATRA treatment significantly reduced the 10 urine Pi/Cr and Ca/Cr ratios, which had been increased by VAD (Table 1) 
. Levels of plasma 11
Pi-regulating hormones (1,25[OH] 2 D 3 , PTH, and FGF23) did not differ between VAD and 12 control rats. In VAD rats, the plasma PTH level was not affected by ATRA, whereas the plasma 13 1,25(OH) 2 D 3 and FGF23 levels were significantly reduced by ATRA (Table 1) . The 14 Na + -dependent Pi uptake activity-but not the Na + -independent Pi uptake activity-in renal 15
BBMVs was markedly decreased in VAD rats, which was significantly increased by ATRA 16 treatment ( Figure 1A ). As we previously reported, Western blotting revealed that the expression 17 levels of renal Npt2a and Npt2c proteins in VAD rats were significantly decreased in 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 Biochemical Journal. This is an Accepted Manuscript. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date-version is available at https://doi.org/10.1042/BCJ20190716 comparison to controls. Furthermore, the decreased expression of Npt2c protein-but not 1
Npt2a-in the kidney of VAD mice was partially restored by ATRA treatment ( Figure 1B ). Next, 2 we performed real-time PCR to measure the renal Npt2a and Npt2c mRNA expression. The 3 decreased mRNA levels of renal Npt2a and Npt2c in VAD rats were significantly increased by 4 ATRA treatment ( Figure 1C) . 5 6 ATRA reduces VAD-induced Pi absorption through the expression of the Npt2b gene in the 7 rat jejunum 8
Because Pi homeostasis is strictly controlled by intestinal absorption and renal excretion, we 9 next investigated whether ATRA regulates the Pi absorption and Npt2b expression in the 10 intestine. We used the jejunum for this analysis because the levels of Npt2b protein and mRNA 11 in the jejunum are higher than those in the duodenum and ileum of rats [10] . As expected, the 12 fecal Pi excretion in VAD rats was significantly decreased in comparison to controls (Table 1) . 13
The Na + -dependent Pi uptake activity in intestinal BBMVs was markedly increased in VAD rats, 14 and this was significantly reduced by ATRA treatment (Figure 2A However, the jejunal PiT1 and PiT2 mRNA expression levels were not changed among three 1 groups (data not shown). 2 Because the expression of the Npt2b gene has been detected in various tissues, including 3 the small intestine, lung, kidney, and liver [18] , we also investigated the effects of ATRA on the 4
Npt2b mRNA expression in several extraintestinal organs by real-time PCR. Unlike the jejunum, 5
the Npt2b mRNA expression in the duodenum and ileum was low, and was not changed among 6 three groups of rats ( Figure 2C ). In the lung, the Npt2b mRNA expression was considerably 7
high, but was not changed among three groups. The hepatic Npt2b mRNA expression was 8 regulated by ATRA, similarly to the jejunum. ATRA did not affect the reduced expression of the 9 renal Npt2b mRNA in VAD rats. The expression of Npt2b mRNA was almost undetectable in 10 the spleen. 11 12 ATRA downregulates the transcriptional activity of the rat Npt2b gene promoter 13
We previously reported that the transcriptional activities of human Npt2a and Npt2c genes are 14 controlled by ATRA and its receptors [4] . To investigate the molecular mechanisms underlying 15 the regulation of the Npt2b gene expression by ATRA, we examined the responsiveness of rat 16
Npt2b gene promoters to ATRA using a luciferase assay. Because we thought that the effects 17 of ATRA on the Npt2b gene expression differ among tissues, we used NIH3T3 cells for a luciferase assay to eliminate tissue specific factor. prNp2b-1.8k, phNp2b-1.5k, and 1 pmNp2b-1.7k reporter constructs, which respectively contained the promoter and exon 1 2 fragments of the rat, human, and mouse Npt2b gene, were utilized for a luciferase assay in 3 NIH3T3 cells. While ATRA had little impact on the transcriptional activity of prNp2b-1.8k 4 without the overexpression of RARRXR in NIH3T3 cells, its activity was markedly inhibited 5 by co-overexpressing RARs (RAR RARor RAR)/RXR (Figurer 3A) . Furthermore, ATRA 6 additively reduced the promoter activity of rat Npt2b that was reduced by the overexpression of 7
RARsRXR in NIH3T3 cells ( Figure 3A ). Next, ATRA dose-dependently reduced the rat Npt2b 8 gene promoter activity in NIH3T3 cells overexpressing RAR/RXR, as well as TTNPB, an 9 RAR-specific agonist ( Figure 3B ). The phNp2b-1.5k and pmNp2b-1.7k reporter constructs 10 exhibited similar responses to ATRA and TTNPB, as did prNp2b-1.8k ( Supplementary Figure  11 S2). A histone modification, a covalent post-translational modification (PTM), such as histone 12 acetylation and methylation, is involved in regulating the transcription [37] . To test whether the 13 inhibition of the Npt2b gene promoter activity by ATRA is associated with the effects of histone 14 acetylation and methylation, we determine the luciferase activity of prNp2b-1.8k with 15
Trichostatin A (histone deacetylase inhibitor, TSA) or 5-aza-2deoxycytidine (methylation 16 inhibitor, 5-Aza-2dc). Neither TSA nor 5-Aza-2dc affected the suppression of the luciferase 17 activity of prNp2b-1.8k by ATRA ( Figure 3C) . In the search for conserved putative regulatory elements, the sequence of the rat Npt2b gene 3 promoter region (−207 to +33) relative to the transcriptional start site was compared to the 4 corresponding regions of the human (−146 to +83) and mouse (−172 to +49) sequences. As 5 shown in Figure 4 (A), highly conserved nucleotide sequences were determined among human, 6 rat, and mouse Npt2b gene promoters with a minimal sequence similarity of 73%. Interestingly, 7 a search for transcription factor binding motifs within this region suggested some potential 8 consensus binding site such as GC-box, C/EBP, and E-box ( Figure 4A ). In order to understand 9 the molecular mechanisms underlying the responsiveness of these Npt2b genes to ATRA, 10 several reporter constructs lacking portions of the 5'-promoter region of the human, rat, and 11 mouse Npt2b genes were tested in NIH3T3 cells overexpressing RAR/RXR, with or without 12 ATRA. These deletion analyses suggest that the C/EBP binding site in the Npt2b gene promoter 13 is involved in the downregulation of the transcriptional activity of the Npt2b gene by ATRA and 14 its receptors ( Figure 4B) . 15
16

RAR/RXR blocks the binding of C/EBP to the Npt2b gene promoter 17
To further test whether the C/EBP binding site is the first target of the downregulation of 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 the Npt2b gene promoter by ATRA and its receptors, we determined the luciferase activity of 1 prNp2b-Mut-GC-box (rMut-G), prNp2b-Mut-C/EBP (rMut-C), and prNp2b-Mut-E-box 2 (rMut-E), the sequences and constructs of which are shown in Figure 5(A) . These mutation 3 analyses showed that the C/EBP binding site-but not GC-box or E-box-was essential for the 4 repression of the Npt2b gene promoter activity by ATRA ( Figure 5B and Supplementary Figure  5 S3C). Next, we investigated how the transcriptional factor C/EBP actually contributes to the 6 suppression of the transcriptional activity of the Npt2b gene by ATRA and its receptors. The 7 overexpression of C/EBP or C/EBP each increased the promoter activity of the rat Npt2b 8 construct to more than double the original level. However, ATRA additively diminished the 9 transcriptional activity of the Npt2b gene, which was reduced by the overexpression of 10 RAR/RXR ( Figure 5C ). Next, we analyzed levels of mRNA expression of C/EBP and 11 C/EBP in NIH3T3 cells using qPCR analysis with the absolute standard curve method.
12
Unlike C/EBP, C/EBP gene was not expressed at all in NIH3T3 cells. Therefore, we 13 selected C/EBPfor gene knockdown experiments, but not C/EBP. We generated NIH3T3 14 cells with the knockdown of C/EBP endogenous C/EBP mRNA levels of which were 15 reduced by more than 50%, using C/EBP-specific siRNA (data not shown). As shown in 16 Biochemical Journal. This is an Accepted Manuscript. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date-version is available at https://doi.org/10.1042/BCJ20190716 the reduction of the Npt2b gene promoter activity by ATRA ( Figure 5E ). Next, to elucidate how 1 ATRA and its receptors downregulate the transcriptional activity of the Npt2b gene through the 2 action of C/EBP, we examined whether RAR/RXR affects the binding of C/EBP to the Npt2b 3 gene promoter by an EMSA analysis. As shown in Figure 5 (F), a radiolabeled 4 oligonucleotide containing an Npt2b-C/EBP probe detected a band in nuclear extracts prepared 5 from NIH3T3 cells overexpressing C/EBPbut not RAR/RXR. Although these complexes are 6 susceptible to competition with unlabeled Npt2b-C/EBP, consensus C/EBP, and an antibody 7 against C/EBP, unlabeled mutated oligonucleotide (Mut: mutated Npt2b-C/EBP) did not 8 compete with these complexes. The formation of these complexes with C/EBP was inhibited 9
in the presence of nuclear extracts prepared from NIH3T3 cells overexpressing RAR/RXR 10 ( Figure 5F ). Likewise, although in vitro synthesized C/EBPrecombinant protein bound to this 11 probe, this DNA-protein complex was inhibited by RARRXR recombinant protein and an 12 antibody against C/EBP(Supplementary Figure S4) . 13 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 Biochemical Journal. This is an Accepted Manuscript. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date-version is available at https://doi.org/10.1042/BCJ20190716
Discussion 1
In the present study, we have determined that the reduction of the intestinal Pi uptake activity 2 and the Npt2b expression in VAD rats were ameliorated by ATRA treatment. Furthermore, we 3 revealed that ATRA reduced the transcriptional activity of the Npt2b gene by inhibiting the 4 binding of C/EBP to the Npt2b gene promoter. Previously, we reported that VAD induced 5 hyperphosphaturia through the downregulation of the Npt2a and Npt2c gene expression in the 6 kidney, without changing the plasma Pi levels [4] . From these inconsistent results, we 7 hypothesized that ATRA might affect not only renal Pi reabsorption but also intestinal Pi 8 absorption. In this study, we found that ATRA increased the renal Pi uptake through the 9 induction of the expression of the Npt2a and Npt2c genes, the levels of which are reduced by 10 VAD, whereas the VAD-induced uptake of Pi via the Npt2b gene expression in the jejunum of 11 VAD rats was reduced by the administration of ATRA. Together, these results suggested that 12 ATRA did not change the plasma Pi levels because of the opposite effects of ATRA on the 13 intestinal Pi uptake and the renal Pi uptake. This is the first report to demonstrate the presence 14 of a Pi regulating factor that has opposite effects on the expression patterns of Npt2a and Npt2c 15 in the kidney and Npt2b in the intestine. However, intestinal Pi absorption is mediated by two 16 pathways: sodium-dependent Pi transport by Npt2b and PiT1/2 via a transcellular pathway; 17 and sodium-independent Pi transport via a paracellular pathway [16] . It was recently reported that tenapanor, an inhibitor of the sodium/hydrogen exchanger (NHE3), 1 significantly reduced intestinal Pi absorption in healthy volunteers and improved 2 hyperphosphatemia in both rodents and humans with CKD [16] . The conformational change 3 of the tight junctions in the enterocytes by NHE3 inhibition leads to increased 4 transepithelial electrical resistance, which contributes to the reduction in permeability to 5 phosphate. Interestingly, it has been reported that retinoic acid can enhance the intestinal 6 epithelial barrier by increasing tight junction protein levels [38, 39] . It was suggested that 7 ATRA reduces intestinal Pi absorption through not only a reduction of the Npt2b expression 8 but also the enhancement of the tight junction function in intestinal enterocytes. These data 9 and reports suggest that ATRA regulates Pi homeostasis in the body through the positive and 10 negative regulation of Pi (re)absorption in the kidney and jejunum. Interestingly, it has been 11 suggested that a gut-derived factor called intestinal phosphatonin is released in response to 12 ingestion of dietary Pi and rapidly modulates renal Pi reabsorption to prevent large post-prandial 13 fluctuations in serum phosphate levels [16] . Although a large part of intestinal phosphatonin 14 remains unclear, ATRA may affect this unknown factor. 15
Intestinal Pi absorption is modulated by 1,25(OH) 2 D 3 as a positive regulator and by FGF-23 16 as a negative regulator [9, 11] . In the present study, the levels of plasma 1,25(OH) 2 D 3 and 17 FGF-23 did not differ between VAD and control rats, as previously reported [4] , whereas the 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 Biochemical Journal. This is an Accepted Manuscript. You are encouraged to use the Version of Record that, when published, will replace this version. The most up-to-date-version is available at https://doi.org/10.1042/BCJ20190716 treatment of VAD rats with ATRA reduced the plasma 1,25(OH) 2 D 3 and FGF-23 levels. We 1 considered that ATRA might reduce the plasma FGF23 levels in VAD rats through the reduction 2 of the plasma 1,25(OH) 2 D 3 levels, because 1,25(OH) 2 D 3 is positive regulator of the FGF23 gene 3 expression [40] . However, it also remains unclear why ATRA reduced the plasma 1,25(OH) 2 D 3 4 levels in VAD rats. Interestingly, an experiment to investigate the effects of retinol and retinoic 5 acid on metabolism of 25(OH)D (which is converted to 1,25[OH] 2 D 3 by CYP27B1 and which is 6 converted to 24,25(OH) 2 D by CYP24A1) in kidney cell culture may answer to this question. 7
Treatment with retinoic acid-but not retinol-for 6 h reduced the production of 1,25(OH) 2 D 3 8 and increased the production of 24,25(OH) 2 D in kidney cells [41] . These findings suggest that 9 the administration of ATRA to VAD rats might reduce plasma 1,25(OH) 2 D 3 levels through the 10 reduction of the conversion of 25(OH)D to 1,25(OH) 2 D 3 . Furthermore, these observations 11 suggest that the VAD-mediated upregulation of the Npt2b gene expression was independent of 12 the plasma 1,25(OH) 2 D 3 and FGF-23 levels, whereas the ATRA-mediated downregulation of the 13 Npt2b gene expression in VAD rats could be partially induced by decreased plasma 14 1,25(OH) 2 D 3 . Although it has been reported that 1,25(OH) 2 D 3 induces Npt2b gene promoter 15 activity, a classical vitamin D responsive element (VDRE) in the Npt2b gene promoter has not 16 been identified [42] . 17
We reported that the transcriptional activity of human Npt2a and Npt2c genes was 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 upregulated by ATRA and its receptors [4] . Thus, we hypothesized that ATRA might control the 1 expression of the Npt2b gene through the regulation of transcription. While ATRA had little 2 impact on the transcriptional activity of prNp2b-1.8k without the overexpression of RARRXR 3 in NIH3T3 cells, its activity was markedly inhibited by co-overexpressing RARs/RXR without 4 the addition of ATRA. Furthermore, ATRA additively reduced the promoter activity of rat Npt2b 5 that was reduced by the overexpression of RARsRXR in NIH3T3 cells. These results may 6 suggest that RAR/RXR is more important for the downregulation of the transcriptional 7 activity of rat Npt2b gene than ATRA. On the other hand, the promoter activity of the Npt2b we have investigated whether ATRA regulates the C/EBP expression in the small intestine 13 of rats, the jejunal C/EBP and C/EBP mRNA expression levels remained unchanged in 14 VAD rats and VAD rats treated with ATRA (data not shown). Furthermore, ATRA treatment 15 did not affect the C/EBP mRNA expression in NIH3T3 cells (data not shown). Next, oligonucleotide containing an Npt2b-C/EBP probe. Surprisingly, it has been reported that 1 C/EBP could bind to the glucocorticoid receptor and RAR [44, 45] . We also demonstrated 2 that RAR/RXR inhibited the binding of C/EBP to the promoter of the Npt2b gene using an 3 EMSA analysis. These data suggest that liganded RAR/RXR inhibits the binding C/EBP or 4 C/EBP to the C/EBP binding site in the Npt2b gene promoter, resulting in the suppression 5 of the transcription activity of the Npt2b gene. Interestingly, we found that ATRA has a 6 distinct effect on the expression patterns of Npt2b mRNA in different organs. C/EBPs 7 (C/EBP, , , , , and ), which are expressed at different levels in each tissue, 8 respectively regulate the diversity and specificity of the complex patterns of gene regulation 9 [22, 23] . That is to say, the difference in the C/EBPs gene expression levels in each tissue 10 may contribute to a distinct effect on the Npt2b mRNA expression patterns by VAD and 11 ATRA treatment in these tissues. We also reported that a complex of C/EBP and activating 12 transcription factor-4 (ATF4) activates the expression of type III sodium-dependent Pi 13 co-transporters (PiT1 and PiT2) through transcriptional regulation [27] . Because C/EBP might 14 be involved in the regulation of Pi homeostasis in various ways, further studies are necessary to 15 fully elucidate the underlying mechanisms. 16
Hyperphosphatemia, which is associated with the pathophysiology of CKD, can lead to 17 vascular calcification, which has been linked to increased cardiovascular morbidity and 18 Downloaded from https://portlandpress.com/biochemj/article-pdf/doi/10.1042/BCJ20190716/867328/bcj-2019-0716.pdf by guest on 15 February 2020 mortality [15] . From studies on the regulation of intestinal Pi transport and metabolism, 1 researchers have targeted Npt2b for alleviating the hyperphosphatemia of CKD [17] . Niacin and 2 its derivative nicotinamide have been reported to reduce the Npt2b expression and lower the 3 plasma Pi levels in CKD animals [46, 47] . However, the exact mechanism through which these 4 compounds reduce intestinal Pi absorption has not been completely elucidated. Interestingly, 5
Fujimori et al. showed that niacin reduced the expression of C/EBP mRNA in the early phase 6 of adipogenesis [48] . In other words, the molecular mechanism through which niacin diminishes 7 the expression of Npt2b may be associated with the reduction of the C/EBP expression by 8 niacin. In the present study, we indicated that ATRA reduces the transcriptional activity of the 9
Npt2b gene by inhibiting the binding of C/EBP to the Npt2b gene promoter. That is to say, 10 ATRA and C/EBP may become therapeutic targets for the prevention of hyperphosphatemia in 11 CKD. Interestingly, elevated plasma retinol, ATRA, and retinol binding protein 4 (RBP4) levels 12 have been observed in CKD patients and animal models [49, 50] . However, the effects of ATRA 13 on intestinal Pi absorption focusing on the expression of Npt2b through the action of C/EBP in 14 CKD are not understood. The clarification of these effects would be valuable for advancing the 15 treatment of CKD. 16
In conclusion, our findings reveal that the downregulation of the intestinal Npt2b gene and 17 the upregulation of the renal Npt2a and Npt2c gene expression by ATRA contributes to Pi 18 
